Jordi Ahnert
Professor, Investigational Cancer Therapeutics · University of Texas M D Anderson Cancer Center
Credentials: · · · · ·
History
- 2018–2020
Drug and Medical Device Development: A Strategic Approach
- 1996–2000
Doctor of Medicine
Research
Actively personalized vaccination trial for newly diagnosed glioblastoma
Nature · 2019 · 754 citations
Nature Communications · 2015 · 710 citations
Development of PI3K inhibitors: lessons learned from early clinical trials
Review · Nature Reviews Clinical Oncology · 2013 · First of 4 authors · Corresponding · 647 citations
50 papers
38 papers
36 papers
35 papers
35 papers
34 papers
32 papers
- DK
29 papers
Clinical trials
- 2022–2023
YL-13027 in Patients With Advanced Solid Tumors
Principal investigator · Unknown · Phase 1
Shanghai YingLi Pharmaceutical Co. Ltd.
- 2019
Study of Oral PQR309 in Patients With Advanced Solid Tumors
Principal investigator · Completed · Phase 1
PIQUR Therapeutics AG
- 2013–2016
A Phase 1/2A Study of LAM561 in Adult Patients With Advanced Solid Tumours
Principal investigator · Completed · Phase 1, Phase 2
Laminar Pharmaceuticals
- 2025–2027
Site PI · Recruiting · Phase 1, Phase 2
Tango Therapeutics, Inc.